The US and EU finalized a trade deal, revealing details on tariffs for pharmaceuticals and semiconductors. A 15% blanket tariff on EU exports to the US was agreed upon, alongside a €750 billion EU commitment to purchase US energy and €600 billion in US investment. While the EU will eliminate tariffs on US industrial goods, concerns remain about the deal’s balance. Pharmaceutical tariffs are capped at 15%, and the US will apply its MFN drug pricing policy only to generics. The agreement does not alter the EU’s digital services act.
